Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 5/20 | 0.50 |
| ▸ | WIZ | O95785 | 6/20 | 0.49 |
| ▸ | IKZF2 | Q9UKS7 | 9/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21618024 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL30326269 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL21618065 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL24079612 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL21618156 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL25087535 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL30326878 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL24079853 | 1.00 | CRBN (0.50) | CRBNWIZIKZF2 | |
| SCHEMBL26022859 | 0.93 | WIZ (0.42) | CRBNWIZIKZF2 | |
| SCHEMBL24079845 | 0.92 | IKZF2 (0.51) | CRBNWIZIKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570625-B2 | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | NOVARTIS AG (CH) | 2026-03-10 | — | — | US | claimed |
| EP-4165169-A1 | ZBTB32 INHIBITORS AND USES THEREOF | Novartis AG (CH) | 2023-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570625-B2 | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | IKZF1, IKZF2, BCL6 | CRBN 148/4885WIZ 531/4885IKZF2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.